Controversy Surrounding New Zealand's E-Cigarette Quit Smoking Program

Jan.02

New Zealand Health Ministry to provide e-cigarette starter kits to aid adult smoking cessation, drawing criticism from health advocates.

According to NZ Herald on January 2nd, Casey Costello, the Deputy Minister of Health in New Zealand, announced that starting next week, e-cigarette starter kits will be provided to smoking cessation services nationwide to assist adults in quitting smoking. However, this move has been criticized by health advocates.

Letitia Harding, CEO of the Asthma and Respiratory Foundation, expressed concerns about the controversial practice of using e-cigarettes to quit smoking.

These products have not yet been approved for smoking cessation by the World Health Organization, the FDA (U.S. Food and Drug Administration), or the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Therefore, distributing these medications as therapeutic products without going through proper rigorous consultation procedures is truly bizarre. They are set to launch this plan next week, which seems too insane.

Harding noted that the plan lacks details and simply involves moving people from one product to another without a clear exit strategy.

Which products will actually receive funding, and how will they actually break free from long-term nicotine dependence on e-cigarette products? In the next decade or few decades, we may see a "New Zealand without e-cigarettes.

References:

[1] Smokefree advocates question Government's vaping plan

Also Read:

[1] New Zealand Government to Provide Free E-cigarette Starter Packs

[2] New Zealand Strengthens Regulation on E-Cigarettes: Disposable Ban Effective from June, 2025

[3] New Zealand Government Passes Strict Anti-Smoking Regulations

#Legislation #Open system e-cigarettes #Market #Australia #Oceania #New Zealand

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches

CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.

Nov.04

Philip Morris International and an Italian Design Brand Launch Limited-Edition IQOS Collaboration, Debuting in Japan Before Expanding to 13 Travel Retail Markets

Philip Morris International (PMI) has partnered with Italian design brand Seletti on a limited-edition IQOS collaboration, unveiled at Milan’s Pirelli HangarBicocca. The collection features two models, launching first in Japan before rolling out to 13 global travel retail markets. PMI says the partnership leverages design and cultural storytelling to advance its smoke-free transition.

Oct.28 by 2FIRSTS.ai

2Firsts Observation｜ZYN Launches Brand Advertisement at Dubai International Airport, Promoting Itself as “World’s No.1 Nicotine Pouch Brand”

2Firsts observed that Philip Morris International’s (PMI) nicotine pouch brand ZYN has launched digital screen advertisements and product displays at the Dubai International Airport Duty Free area, featuring flavors such as Spearmint, Black Cherry, and Cool Mint, while promoting itself with the slogan “World’s No.1 Nicotine Pouch Brand.”

Nov.13 by 2FIRSTS.ai

Mexico’s Congress Prepares Total Ban on Vapes and E-Cigarettes

Mexico’s Chamber of Deputies is preparing to vote on several major bills before the end of the legislative session, including a full ban on vapes and e-cigarettes. The proposed reform to the General Health Law would prohibit the manufacturing, sale, import, and export of these products, imposing penalties of up to eight years in prison and fines exceeding 200,000 pesos (approximately USD 11,000). L